Cargando…

Reduction of conspicuous facial pores by topical fullerene: possible role in the suppression of PGE(2) production in the skin

BACKGROUND: Conspicuous facial pores are therapeutic targets for cosmeceuticals. Here we examine the effect of topical fullerene on conspicuous facial pores using a new image analyser called the VISIA(®) system. Ten healthy Japanese females participated in this study, and they received applications...

Descripción completa

Detalles Bibliográficos
Autores principales: Inui, Shigeki, Mori, Ayako, Ito, Masayuki, Hyodo, Sayuri, Itami, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940024/
https://www.ncbi.nlm.nih.gov/pubmed/24559044
http://dx.doi.org/10.1186/1477-3155-12-6
Descripción
Sumario:BACKGROUND: Conspicuous facial pores are therapeutic targets for cosmeceuticals. Here we examine the effect of topical fullerene on conspicuous facial pores using a new image analyser called the VISIA(®) system. Ten healthy Japanese females participated in this study, and they received applications of 1% fullerene lotion to the face twice a day for 8 weeks. FINDINGS: Fullerene lotion significantly decreased conspicuous pores by 17.6% (p < 0.05, Wilcoxon signed-rank test) after an 8-week treatment. A self-administered questionnaire indicated that this reduction achieved cosmetically appreciable effects. In addition, to investigate the mechanism of effect of fullerene, we examined its effect on UVB-induced prostaglandin E(2) (PGE(2)) production in reconstructed human epidermis (RhE). The results showed that irradiation of RhE with 1000 mJ/cm(2) increased PGE(2) production by 62.3% (p < 0.05, Mann-Whitney U-test) and the addition of 28 μM fullerene significantly suppressed the UVB-induced PGE(2) production by 18.3% (p < 0.05). CONCLUSIONS: Fullerene lotion significantly decreases conspicuous facial pores after an 8-week treatment possibly through the suppression of PGE(2) production in the epidermis.